MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2026 International Congress

    Plasma p-tau217 outperforms p-tau181 as a biomarker of Alzheimer’s disease co-pathology in the Lewy Body Disorders spectrum

    E. Fiorenzato, S. Cauzzo, G. Musso, R. Biundo, C. Ceolin, C. Fogliano, C. Cosma, W. Meissner, V. Misenti, S. Moz, ML. Nasi, F. Vianello, R. Manara, M. Montagnana, G. Sergi, A. Antonini (Padova, Italy)

    Objective: To evaluate the relative performance of plasma p-tau217 and p-tau181 as biomarkers of Alzheimer’s disease (AD)  co-pathology across the Lewy body disorders (LBD)  spectrum.…
  • 2026 International Congress

    DTI-Based Comparative Analysis of Microstructural Alterations in Parkinson Disease and Atypical Parkinsonism

    H. Lin, W. Dai (guangzhou, China)

    Objective: Diffusion tensor imaging (DTI) holds promising potential for investigating pathological changes in white matter (WM). In recent years, numerous studies worldwide have demonstrated that…
  • 2026 International Congress

    7 Tesla MRI with Quantitative Susceptibility Mapping: Quantitative focal measurements and qualitative grading of the substantia nigra as a biomarker for Parkinson’s Disease

    R. Unsgård, K. Stige, A. Kristoffersen, P. Goa, C. Tzoulis, E. Berntsen (Trondheim, Norway)

    Objective: To quantitatively and qualitatively evaluate susceptibility changes in the dorsal SN (dSN), using quantitative susceptibility mapping (QSM) and susceptibility-weighted imaging (SWI) at 7Tesla (7T)…
  • 2026 International Congress

    Basal Ganglia Lacunar Infarcts and Risk of Mortality and Dementia in Parkinsonism: A Population-Based Study

    L. Malfer, F. Onorati, A. Mullan, R. Savica (Rochester, USA)

    Objective: To determine the prevalence of chronic basal ganglia lacunar infarcts (BGLI) and examine their association with dementia and mortality in a population-based cohort of…
  • 2026 International Congress

    Remaining unmet needs in Essential Tremor and Parkinson’s Disease: European Neurologists’ Assessments of Pharmacologic Response and Advanced Therapy Use

    N. Kaempf, á. Sánchez Fraga, C. Tengelin, P. Crivelli, K. Gant, C. Ferrer, A. Grinspan (Frankfurt am Main, Germany)

    Objective: To investigate neurologists’ perceptions of treatment effectiveness and criteria for selecting patients for advanced therapies in essential tremor (ET) and Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    Differential Cholinergic White Matter Microstructural Alterations in Multiple System Atrophy and Parkinson’s Disease

    SM. Rong, R. Yang, ZH. Li, XL. Cui, CT. He, MF. Cai, YH. Zhang (Guangzhou, Guangdong Province, China)

    Objective: To investigate the extent and pattern of microstructural alterations of cholinergic pathways in MSA and PD. Background: MSA and PD are both α-synucleinopathies with…
  • 2026 International Congress

    A Diffusion MRI Neurodegeneration Index for Lewy Body Dementia & Alzheimer’s disease

    S. Chiu, R. Chen, W. Wang, J. Desimone, A. Barmpoutis, M. Armstrong, D. Vaillancourt (Scottsdale, USA)

    Objective: To develop a diffusion MRI-based neurodegeneration index using free-water imaging and assess its ability to quantify neurodegenerative burden in Lewy body dementia (LBD) and…
  • 2026 International Congress

    Redefining Anatomical Boundaries, An Atypical Case of MV-PLUS with Supratentorial extension.

    W. Trillo Alvarez, D. Cahuana Ibarra, C. Pinto Torres, C. Ibañez Escalante, K. Choque Pereyra, S. Paliza Huamani, M. Nieto Rosas, S. Meza Caceres, G. Delacuba Vargas, J. Escalante Ortiz, A. Carpio Peña (AREQUIPA, Peru)

    Objective: To report the first case of Multinodular and Vacuolating Posterior Fossa Lesions of Unknown Significance (MV-PLUS) with atypical supratentorial temporal extension, expanding the known…
  • 2026 International Congress

    The utility of HbA1c in Predicting Neuroimaging Findings in Diabetic Striatopathy – A Systematic Review

    L. D’Souza, G. Srinivasa, K. Reddy, D. T, D. Sanjaya, S. Katti, R. Agarwal, M. Singhvi (Bangalore, India)

    Objective: To explore the impact of HbA1c on imaging in Diabetic Striatopathy. Background: Diabetic Striatopathy (DS) is a rare neurological complication of hyperglycemia. While glycemic…
  • 2026 International Congress

    PET Imaging of Presynaptic Terminals with [18F]SynVesT-1 in Premanifest Huntington’s Disease

    J. van Opstal, G. Vanderlinden, A. Delva, K. van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To assess synapse loss in vivo in late premanifest Huntington’s disease (HD) subjects using [18F]SynVesT-1 positron emission tomography (PET). Background: Synaptic damage is believed…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 88
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley